What is GeniPhys?
GeniPhys is at the forefront of developing and commercializing advanced collagen materials. Their innovative approach focuses on custom design and fabrication of collagen to accelerate and improve tissue restoration and regeneration processes. Based in Zionsville, Indiana, the company's work holds substantial promise for the regenerative medicine sector.
How much funding has GeniPhys raised?
GeniPhys has raised a total of $9M across 2 funding rounds:
Series A
$6M
Private Equity
$3M
Series A (2023): $6M with participation from Pier 70 Ventures and Elevate Ventures
Private Equity (2026): $3M, investors not publicly disclosed
Key Investors in GeniPhys
Pier 70 Ventures
Pier 70 Ventures is a venture capital firm that invests in innovative, impact-driven technologies, particularly in healthcare, aiming to accelerate high-growth sustainable companies through capital and mentorship.
Elevate Ventures
Elevate Ventures is an Indiana-based firm that invests in cross-sector innovation-driven companies at early stages, providing funding and guidance to entrepreneurs with promising ideas.
What's next for GeniPhys?
The substantial enterprise-level funding and recent strategic investment indicate GeniPhys is poised for significant scaling and market expansion. This capital infusion will likely fuel further research and development, enhance manufacturing capabilities, and support broader clinical trials or market penetration efforts. The company's trajectory suggests a move towards solidifying its position as a leader in custom collagen solutions for tissue repair.
See full GeniPhys company page
